Parkinson’s is a progressive incurable brain disease estimated to affect more than 10 million people worldwide. The disease affects physical movement, but it also exacts a social toll. Sufferers drop activities, relinquish […]
A meta-analysis conducted and co-authored by Quantify’s Joel Gunnarsson and Rosa Lauppe shows that supplementation with nutritional vitamin D is not effective in reducing parathyroid hormone (PTH) in patients with non-dialysis chronic kidney disease. However, it […]
Quantify’s Gustav Segerberg was using his excellent presenting skills in front of a camera last week. The final product will be released soon. Stay tuned!
#moviestar #inspelningpågår #rwe #marketaccess […]
Today on International Women’s Day, Quantify celebrates all the brilliant female minds of science and medicine throughout history. Often in the face of prejudice and discrimination, these women have made outstanding medical […]
Our CEO Kirk Geale was recently interviewed in the newspaper of Psoriasisförbundet about the links between psoriasis and mental health, based on research published in JAMA […]
The unavailability of medicines can be both problematic and lead to severe consequences for patients in need of therapy. However, in many cases other treatment alternatives can be provided. Quantify, in collaboration […]
At Quantify we are very proud of our research because of its positive impact on patients and the research community. Our CEO Kirk Geale proudly looks forward to our 2021 projects:
“We have such a great team at Quantify and I am continuously […]
Quantify’s Emma Söreskog, Ingrid Lindberg, Oskar Ström and Fredrik Borgström have co-authored two recently published papers on cost-effectiveness modelling in osteoporosis. One of the papers presents a […]
2020 has been a year of challenge and change for Quantify, the life science industry and society at large. We are heartened by the way people have come together to support one another, and this year we are especially proud […]
